SUNVAX MRNA THERAPEUTICS - Trademark Details
Status: 630 - New Application - Record Initialized Not Assigned To Examiner
Serial Number
98107092
Word Mark
SUNVAX MRNA THERAPEUTICS
Status
630 - New Application - Record Initialized Not Assigned To Examiner
Status Date
2023-08-01
Filing Date
2023-07-28
Attorney Name
Statements
Indication of Colors claimed
The color(s) light blue, orange and yellow is/are claimed as a feature of the mark.
Description of Mark
The mark consists of an image of the sun in orange, bordered in yellow with a blue strand superimposed on blue wings followed by the words SUNVAX MRNA THERAPEUTICS in blue; The white background is a transparent or background area and is not part of the mark.
Goods and Services
Lipids, mRNA, Lipid nanoparticle-mRNA, and their related products and services for industry and science
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2023-08-01
Primary Code
001
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
DANIEL L. SHORES
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2023-08-01 | NEW APPLICATION ENTERED |